title: Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p.
abstract: Multiple chromosome 3p tumor suppressor genes (TSG) have been proposed in the pathogenesis of ovarian cancer based on complex patterns of 3p loss. To attain functional evidence in support of TSGs and identify candidate regions, we applied a chromosome transfer method involving cell fusions of the tumorigenic OV90 human ovarian cancer cell line, monoallelic for 3p and an irradiated mouse cell line containing a human chromosome 3 in order to derive OV90 hybrids containing normal 3p fragments. The resulting hybrids showed complete or incomplete suppression of tumorigenicity in nude mouse xenograft assays, and varied in their ability to form colonies in soft agarose and three-dimensional spheroids in a manner consistent with alteration of their in vivo tumorigenic phenotypes. Expression microarray analysis identified a set of common differentially expressed genes, such as SPARC, DAB2 and VEGF, some of which have been shown implicated in ovarian cancer. Genotyping assays revealed that they harbored normal 3p fragments, some of which overlapped candidate TSG regions (3p25-p26, 3p24 and 3p14-pcen) identified previously in loss of heterozygosity analyses of ovarian cancers. However, only the 3p12-pcen region was acquired in common by all hybrids where expression microarray analysis identified differentially expressed genes. The correlation of 3p12-pcen transfer and tumor suppression with a concerted re-programming of the cellular transcriptome suggest that the putative TSG may have affected key underlying events in ovarian cancer.
authors.affiliation: Department of Human Genetics, McGill University, Montréal, Canada.
authors.forename: N A L
authors.initials: NA
authors.lastname: Cody
authors.forename: V
authors.initials: V
authors.lastname: Ouellet
authors.forename: E N
authors.initials: EN
authors.lastname: Manderson
authors.forename: M C J
authors.initials: MC
authors.lastname: Quinn
authors.forename: A
authors.initials: A
authors.lastname: Filali-Mouhim
authors.forename: P
authors.initials: P
authors.lastname: Tellis
authors.forename: M
authors.initials: M
authors.lastname: Zietarska
authors.forename: D M
authors.initials: DM
authors.lastname: Provencher
authors.forename: A-M
authors.initials: AM
authors.lastname: Mes-Masson
authors.forename: M
authors.initials: M
authors.lastname: Chevrette
authors.forename: P N
authors.initials: PN
authors.lastname: Tonin
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics*; D000818:Animals; D045744:Cell Line, Tumor; D002869:Chromosome Aberrations; D002893:Chromosomes, Human, Pair 3; D005260:Female; D020869:Gene Expression Profiling; D018014:Gene Transfer Techniques; D016147:Genes, Tumor Suppressor / Q000502:physiology*; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D010051:Ovarian Neoplasms / Q000235:genetics*; D023041:Xenograft Model Antitumor Assays